WO2004013278A3 - Expression vectors - Google Patents

Expression vectors Download PDF

Info

Publication number
WO2004013278A3
WO2004013278A3 PCT/KR2003/001555 KR0301555W WO2004013278A3 WO 2004013278 A3 WO2004013278 A3 WO 2004013278A3 KR 0301555 W KR0301555 W KR 0301555W WO 2004013278 A3 WO2004013278 A3 WO 2004013278A3
Authority
WO
WIPO (PCT)
Prior art keywords
chain variable
variable region
antibody
expression vectors
expression vector
Prior art date
Application number
PCT/KR2003/001555
Other languages
French (fr)
Other versions
WO2004013278A2 (en
Inventor
Jong-Wook Lee
In-Young Ko
Moo-Young Song
Chang-Seok Kim
Jae-Sun Lee
Tae-Hyoung Yoo
Ji-Min Kim
Sang-Koo Park
Original Assignee
Yuhan Corp
Jong-Wook Lee
In-Young Ko
Moo-Young Song
Chang-Seok Kim
Jae-Sun Lee
Tae-Hyoung Yoo
Ji-Min Kim
Sang-Koo Park
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020020045768A external-priority patent/KR100604037B1/en
Priority claimed from KR10-2002-0045767A external-priority patent/KR100528772B1/en
Priority claimed from KR1020020045765A external-priority patent/KR100604038B1/en
Application filed by Yuhan Corp, Jong-Wook Lee, In-Young Ko, Moo-Young Song, Chang-Seok Kim, Jae-Sun Lee, Tae-Hyoung Yoo, Ji-Min Kim, Sang-Koo Park filed Critical Yuhan Corp
Priority to AU2003253447A priority Critical patent/AU2003253447A1/en
Publication of WO2004013278A2 publication Critical patent/WO2004013278A2/en
Publication of WO2004013278A3 publication Critical patent/WO2004013278A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies

Abstract

Provided is an expression vector for a heavy chain variable region, a lambda (λ ) light chain variable region, or a kappa (κ ) light chain variable region of an antibody. The expression vector includes a restriction site which commonly exists in joining regions of genes encoding antibody variable regions; and a gene encoding an antibody constant region.
PCT/KR2003/001555 2002-08-02 2003-08-01 Expression vectors WO2004013278A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003253447A AU2003253447A1 (en) 2002-08-02 2003-08-01 Expression vectors

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
KR1020020045768A KR100604037B1 (en) 2002-08-02 2002-08-02 A kafa light chain expression vector
KR10-2002-0045767 2002-08-02
KR10-2002-0045767A KR100528772B1 (en) 2002-08-02 2002-08-02 A lambda light chain expression vector
KR10-2002-0045768 2002-08-02
KR10-2002-0045765 2002-08-02
KR1020020045765A KR100604038B1 (en) 2002-08-02 2002-08-02 A heavy chain expression vector

Publications (2)

Publication Number Publication Date
WO2004013278A2 WO2004013278A2 (en) 2004-02-12
WO2004013278A3 true WO2004013278A3 (en) 2004-06-24

Family

ID=31499138

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2003/001555 WO2004013278A2 (en) 2002-08-02 2003-08-01 Expression vectors

Country Status (2)

Country Link
AU (1) AU2003253447A1 (en)
WO (1) WO2004013278A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6898060B2 (en) * 2012-12-13 2021-07-07 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア DNA antibody construct and how to use it

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840479A (en) * 1990-02-01 1998-11-24 Behring Diagnostics Gmbh Preparation and use of gene banks of synthetic human antibodies ("synthetic human-antibody libraries")
US6214613B1 (en) * 1993-12-03 2001-04-10 Ashai Kasei Kogyo Kabushiki Kaisha Expression screening vector

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840479A (en) * 1990-02-01 1998-11-24 Behring Diagnostics Gmbh Preparation and use of gene banks of synthetic human antibodies ("synthetic human-antibody libraries")
US6214613B1 (en) * 1993-12-03 2001-04-10 Ashai Kasei Kogyo Kabushiki Kaisha Expression screening vector

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
WALLS ET AL: "Vectors for the expression of PCR-amplified immunoglobulin variable domains with human constant regions", NUCLEIC ACIDS RES., vol. 21, no. 12, 25 June 1993 (1993-06-25), pages 2921 - 2929 *

Also Published As

Publication number Publication date
AU2003253447A8 (en) 2004-02-23
WO2004013278A2 (en) 2004-02-12
AU2003253447A1 (en) 2004-02-23

Similar Documents

Publication Publication Date Title
EP2138512B8 (en) Humanized anti-NGF antibodies
WO2003087131A3 (en) Anti-her2 antibody variants
WO2002086083A3 (en) Methods of enhancing cell responsiveness
WO2003018632A3 (en) Epitope regions of a thyrotrophin (tsh) receptor, uses thereof and antibodies thereto
NZ547157A (en) Interferon Alpha Antibodies and their uses
WO2003029458A3 (en) Method for producing protein libraries and for selecting proteins from said libraries
WO2000061622A3 (en) Genes associated with diseases of the kidney
AU2002241866A1 (en) Nucleotide sequences encoding variable regions of heavy and light chains of monoclonal antibody 1f7
WO2003026692A3 (en) Treatment of chronic joint inflammation using an antibody against the cd3 antigen complex
EP1491555A4 (en) Anti-human hepatoma monoclonal antibody hab18 light/heavy chain variable region gene, and use thereof
WO2003050260A3 (en) Streptavidin expressed gene fusions and methods of use thereof
WO2003038397A3 (en) Assay
WO2004013278A3 (en) Expression vectors
WO2002084451A3 (en) Vector processor architecture and methods performed therein
WO2002088315A3 (en) Phagemid vectors
EP1692179A4 (en) An antibody variable region of a monoclonal antibody against human tumor necrosis factor alpha and a gene encoding the same
AU2002362800A1 (en) Modulation of the expression of genes dependent on stat-1
WO2003025134A3 (en) mcFP ENCODING NUCLEIC ACIDS, POLYPEPTIDES, ANTIBODIES AND METHODS OF USE THEREOF
WO2002059227A3 (en) Novel mesogens
WO2002050120A3 (en) High affinity antibodies
WO2001068695A3 (en) Factor-h related protein 5 (fhr-5) and antibodies thereto
AU2002257263A1 (en) Monoclonal antibody for nkx3.1 and method for detecting same
AU2002321923A1 (en) Surface expression vectors having pgsbca, the gene coding poly-gamma-glutamate synthetase, and a method for expression of target protein at the surface of microorganism using the vector
AU2002307691A1 (en) A variable region of the monoclonal antibody against the hbv s-surface antigen and a gene encoding the same
AU2002231806A1 (en) H. influenzae antigen basb213

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP